Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial
American Journal of Nephrology · 2024
DOI: 10.1159/000539451 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Nephrology, 2024. Verfasst von Bróna M Moloney und 2 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Renal Dialysis, Blood Pressure, Hypotension, Kidney Failure, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Diabetes mellitus is a common cause of kidney failure and is often complicated by autonomic neuropathy, which may have implications for blood pressure (BP) homeostasis during hemodialysis (HD).
Methods
In this post hoc analysis of the Frequent Hemodialysis Network (FHN) Daily Trial, we used random effects Poisson and linear regression models to estimate the association of diabetes (vs. not) with intra-dialytic hypotension (IDH) and peri-dialytic BP parameters, respectively. We tested for differential associations according to the randomized treatment (6/week vs. 3/week HD) and pre-HD systolic BP.
Results
Of the 244 patients with intra-dialytic BP data, 100 (41%) had diabetes at baseline. The mean age was 51 ± 14 years; overall, 39% were female. In adjusted models, diabetes (vs. not) was associated with a 93% higher risk of developing IDH (IRR: 1.93; 95% CI: 1.26, 2.95). There was no evidence that the randomized treatment assignment modified the association between diabetes and IDH (pinteraction = 0.32), but more potent associations were noted among those with higher pre-HD systolic BP (pinteraction < 0.001). Diabetes (vs. not) was associated with a lower adjusted nadir intra-HD BP (−4.2; 95% CI: −8.3, −0.2 mm Hg) but not with the pre- or post-HD systolic BP.
Conclusions
Among participants of the FHN Daily Trial, patients with diabetes had a higher risk of IDH and lower nadir intra-HD systolic BP than patients without diabetes, even when undergoing HD up to 6 times per week.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
- Departments of Medicine, Epidemiology and Population Health, and Health Policy, Stanford University School of Medicine, Stanford, California, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Moloney, B. M., Chertow, G. M., & Mc Causland, F. R. (2024). Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. American Journal of Nephrology. https://doi.org/10.1159/000539451
Vancouver
Moloney BM, Chertow GM, Mc Causland FR. Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial. American Journal of Nephrology. 2024. doi:10.1159/000539451
BibTeX
@article{Moloney2024,
author = {Moloney, Bróna M and Chertow, Glenn Matthew and Mc Causland, Finnian R},
title = {Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial},
journal = {American Journal of Nephrology},
year = {2024},
doi = {10.1159/000539451}
}
EUVIMED